Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer
Friday, July 10, 2026
12:15 PM - 1:15 PM MT
This program brings together expert faculty to discuss the latest advances and enable the integration of oral SERDs and emerging combination strategies into HR+/HER2- metastatic breast cancer care.
Community Oncology Connections™: Advancing Precision Care in HER2-Positive Gastroesophageal Adenocarcinomas: A Collective Curriculum on the Integration of Novel Bispecific Antibody Therapy
Friday, September 25, 2026
12:15 PM - 1:15 PM MT
In this series of live, virtual webcasts, experts in the management of esophagogastric adenocarcinoma discuss the evaluation and treatment of HER2-positive disease across the treatment continuum.
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer
Friday, October 30, 2026
12:15 PM - 1:15 PM MT
This online, CME-certified Oncology State Societies at ACCC Meeting Series – How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer, will bring together expert faculty to review the key recent findings and discuss their potential implications for community oncologists.